机译:Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
Univ Basel, Dept Dermatol, Div Allergy, Petersgraben 4, CH-4031 Basel, Switzerland;
Stanford Univ, Sch Med, Stanford, CA 94305 USA;
Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USAUniv Paris 05, Inst Imagine, Ctr Reference Mastocytoses, Paris, FranceUniv Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USAUniv Penn, Philadelphia, PA 19104 USAMem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USANovartis Pharma AG, Basel, SwitzerlandNovartis Pharmaceut, E Hanover, NJ USAParacelsus Med Univ Salzburg, Inst Pathol, Salzburg, AustriaUniv Utah, Salt Lake City, UT USALudwig Maximilian Univ Munich, Munich, GermanyMed Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, AustriaHeidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, GermanyUniv Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands;
Advanced systemic mastocytosis; KIT mutation; mastocytosis; mediator symptoms; midostaurin; quality of life; tryptase; skin lesions of mastocytosis;